Low–molecular-weight heparin therapy for non-ST-elevation acute coronary syndromes and during percutaneous coronary intervention: An expert consensus*

Coronary Intervention ◽

Heparin Therapy ◽

Low Molecular Weight ◽

Percutaneous Coronary ◽

Coronary Syndromes ◽

Low–molecular-weight heparin therapy for non-ST-elevation acute coronary syndromes and during percutaneous coronary intervention: An expert consensus*

American Heart Journal ◽

10.1067/mhj.2002.124405 ◽

2002 ◽

Vol 144 (4) ◽

pp. 615-624

Author(s):

Dean J. Kereiakes ◽

Gilles Montalescot ◽

Elliott M. Antman ◽

Marc Cohen ◽

Harald Darius ◽

...

Keyword(s):

Molecular Weight ◽

Coronary Intervention ◽

Heparin Therapy ◽

Low Molecular Weight ◽

Percutaneous Coronary ◽

Coronary Syndromes ◽

Primary percutaneous coronary intervention for ST-elevation myocardial infarction using an intravenous and subcutaneous enoxaparin low molecular weight heparin regimen

Journal of Thrombosis and Thrombolysis ◽

10.1007/s11239-008-0258-2 ◽

2008 ◽

Vol 26 (2) ◽

pp. 85-90 ◽

Cited By ~ 6

Author(s):

Sargis Khoobiar ◽

Nicolai Mejevoi ◽

Khalil Kaid ◽

Catalin Boiangiu ◽

Sampoornima Setty ◽

...

Keyword(s):

Myocardial Infarction ◽

Molecular Weight ◽

Primary Percutaneous Coronary Intervention ◽

Coronary Intervention ◽

Low Molecular Weight ◽

Percutaneous Coronary ◽

Subcutaneous Enoxaparin ◽

Catheter thrombosis during primary percutaneous coronary intervention for acute ST elevation myocardial infarction despite subcutaneous low-molecular-weight heparin, acetylsalicylic acid, clopidogrel and abciximab pretreatment

Canadian Journal of Cardiology ◽

10.1016/s0828-282x(06)70271-9 ◽

2006 ◽

Vol 22 (6) ◽

pp. 511-515 ◽

Cited By ~ 29

Author(s):

Christopher E. Buller ◽

Gordon E. Pate ◽

Paul W. Armstrong ◽

Blair J. O’Neill ◽

John G. Webb ◽

...

Keyword(s):

Myocardial Infarction ◽

Molecular Weight ◽

Acetylsalicylic Acid ◽

Primary Percutaneous Coronary Intervention ◽

Coronary Intervention ◽

Low Molecular Weight ◽

Percutaneous Coronary ◽

2050 Effects of antithrombotic regimen on the early outcome in the FRACAS study: incremental beneficial effects of low molecular weight heparin and thlenopyridine in patients undergoing subsequent percutaneous coronary intervention

European Heart Journal ◽

10.1016/s0195-668x(03)95047-0 ◽

2003 ◽

Vol 24 (5) ◽

pp. 378

Author(s):

M ANGIOL

Keyword(s):

Molecular Weight ◽

Coronary Intervention ◽

Low Molecular Weight ◽

Early Outcome ◽

Beneficial Effects ◽

Percutaneous Coronary

Early versus delayed percutaneous coronary intervention in patients with non-ST elevation acute coronary syndromes

Coronary Artery Disease ◽

10.1097/mca.0000000000000374 ◽

2016 ◽

Vol 27 (5) ◽

pp. 344-349 ◽

Cited By ~ 3

Author(s):

Matias B. Yudi ◽

Andrew E. Ajani ◽

Nick Andrianopoulos ◽

Stephen J. Duffy ◽

Omar Farouque ◽

...

Keyword(s):

Coronary Intervention ◽

Percutaneous Coronary ◽

Coronary Syndromes ◽

Design and rationale of a study in Asia of atorvastatin pretreatment in patients undergoing percutaneous coronary intervention for non-ST elevation acute coronary syndromes

Journal of Cardiology ◽

10.1016/j.jjcc.2009.12.002 ◽

2010 ◽

Vol 55 (3) ◽

pp. 303-308 ◽

Cited By ~ 3

Author(s):

JunBo Ge ◽

Young-Jo Kim ◽

Yang-Soo Jang ◽

JunRen Zhu ◽

Ian C. Marschner ◽

...

Keyword(s):

Coronary Intervention ◽

Percutaneous Coronary ◽

Coronary Syndromes ◽

Adjunctive Pharmacotherapy before Percutaneous Coronary Intervention in Non-ST-Elevation Acute Coronary Syndromes: The Role of Modulating Inflammation

Circulation ◽

10.1161/01.cir.0000086951.09881.51 ◽

2003 ◽

Vol 108 (90161) ◽

pp. 22III--27 ◽

Cited By ~ 17

Author(s):

D. J. Kereiakes

Keyword(s):

Coronary Intervention ◽

Percutaneous Coronary ◽

Coronary Syndromes ◽

Prognostic significance of preprocedural troponin-I in patients with non-ST elevation acute coronary syndromes undergoing percutaneous coronary intervention

Coronary Artery Disease ◽

10.1097/mca.0b013e32833aa6fa ◽

2010 ◽

Vol 21 (5) ◽

pp. 261-265 ◽

Cited By ~ 3

Author(s):

Sirikarn Napan ◽

Ramesh Chillal Kashinath ◽

Sameer Kadri ◽

Maria N. Orig ◽

Suhail Khadra

Keyword(s):

Troponin I ◽

Prognostic Significance ◽

Coronary Intervention ◽

Percutaneous Coronary ◽

Coronary Syndromes ◽

Current Update on Glycoprotein IIb-IIIa and Direct Thrombin Inhibition in Percutaneous Coronary Intervention for Non-ST Elevation Acute Coronary Syndromes: Balancing Bleeding Risk and Antiplatelet Efficacy

Journal of Interventional Cardiology ◽

10.1111/j.1540-8183.2007.00335.x ◽

2008 ◽

Vol 21 (2) ◽

pp. 107-117 ◽

Cited By ~ 5

Author(s):

ANDREW T. KWA ◽

JASON H. ROGERS

Keyword(s):

Bleeding Risk ◽

Coronary Intervention ◽

Thrombin Inhibition ◽

Percutaneous Coronary ◽

Coronary Syndromes ◽

Low Molecular Weight Heparin Use in Percutaneous Coronary Intervention

Critical Pathways in Cardiology ◽

10.1097/00132577-200209000-00004 ◽

2002 ◽

Vol 1 (3) ◽

pp. 180-183

Author(s):

R??mi Choussat ◽

Jean Philippe Collet ◽

Miles Dalby ◽

Gilles Montalescot

Keyword(s):

Molecular Weight ◽

Coronary Intervention ◽

Low Molecular Weight ◽

Percutaneous Coronary